As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...